GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $154M (100.0% shares, 0.0% debt)

Holdings (26)

IONS IONIS PHARMACEUTICALS INC 12.8%
Value $19.75M Shares 500,000 Est. Cost $35.97 Unrealized -9.0%
RZLT REZOLUTE INC 8.8%
Value $13.53M Shares 3,033,462 Est. Cost $4.03 Unrealized -7.9%
AMLX AMYLYX PHARMACEUTICALS INC 8.3%
Value $12.82M Shares 2,000,000 Est. Cost $3.68 Unrealized +32.1%
LEGN LEGEND BIOTECH CORP 8.1%
Value $12.42M Shares 350,000 Est. Cost $34.87 Unrealized
ABVX ABIVAX SA 6.4%
Value $9.881M Shares 1,291,617 Est. Cost $12.06 Unrealized
NGNE NEUROGENE INC 4.7%
Value $7.264M Shares 485,859 Est. Cost $14.71 Unrealized +6.7%
AKBA AKEBIA THERAPEUTICS INC 4.7%
Value $7.229M Shares 1,985,915 Est. Cost $2.04 Unrealized +34.6%
EOLS EVOLUS INC 4.3%
Value $6.632M Shares 720,118 Est. Cost $9.83 Unrealized +4.1%
ACLX ARCELLX INC 4.3%
Value $6.585M Shares 100,000 Est. Cost $64.73 Unrealized -3.8%
XENE XENON PHARMACEUTICALS INC 4.1%
Value $6.26M Shares 200,000 Est. Cost $41.35 Unrealized -21.1%
AKERO THERAPEUTICS INC 3.6%
Value $5.541M Shares 103,848 Est. Cost $53.36 Unrealized
JBIO JADE BIOSCIENCES INC 3.2%
Value $4.976M Shares 498,054 Est. Cost $33.31 Unrealized 0.0%
CYTK CYTOKINETICS INC 3.2%
Value $4.956M Shares 150,000 Est. Cost $51.61 Unrealized -32.6%
IMVT IMMUNOVANT INC 2.7%
Value $4.195M Shares 262,176 Est. Cost $20.92 Unrealized -27.7%
UNCY UNICYCIVE THERAPEUTICS INC 2.5%
Value $3.8M Shares 796,558 Est. Cost $6.18 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 2.4%
Value $3.653M Shares 323,170 Est. Cost $11.31 Unrealized +8.1%
TSHA TAYSHA GENE THERAPIES INC 2.3%
Value $3.465M Shares 1,500,000 Est. Cost $2.17 Unrealized 0.0%
DBVT DBV TECHNOLOGIES S A 2.2%
Value $3.432M Shares 374,679 Est. Cost $9.16 Unrealized
ZURA ZURA BIO LTD 2.2%
Value $3.329M Shares 3,170,194 Est. Cost $6.43 Unrealized -81.4%
UPB UPSTREAM BIO INC 2.1%
Value $3.294M Shares 300,000 Est. Cost $22.33 Unrealized -58.6%
CNTX CONTEXT THERAPEUTICS INC 2.0%
Value $3.069M Shares 4,683,711 Est. Cost $1.72 Unrealized -58.3%
CNTA CENTESSA PHARMACEUTICALS PLC 1.9%
Value $2.957M Shares 225,000 Est. Cost $13.97 Unrealized
SRRK SCHOLAR ROCK HLDG CORP 1.4%
Value $2.182M Shares 61,607 Est. Cost $31.39 Unrealized 0.0%
PROMIS NEUROSCIENCES INC 0.8%
Value $1.28M Shares 2,645,128 Est. Cost $1.25 Unrealized
PLRX PLIANT THERAPEUTICS INC 0.6%
Value $986K Shares 850,000 Est. Cost $16.18 Unrealized -91.3%
BBOT HELIX ACQUISITION CORP II 0.2%
Value $312K Shares 29,381 Est. Cost $10.35 Unrealized +4.5%